--- title: "EHang Holdings Limited Stock 12‑Month Price Target Cut to $13.15, Implies 87% Upside" type: "News" locale: "en" url: "https://longbridge.com/en/news/290317955.md" description: "EHang Holdings Limited's 12-month average price target was lowered from $13.95 to $13.15 by eight analysts, with individual forecasts ranging from $7.99 to $16.90. Based on the June 18 closing price, this revised target implies an approximate 87% upside potential. Despite the cut, the consensus rating among nine covering analysts remains 'Buy,' comprising seven buys and two holds." datetime: "2026-06-20T04:20:04.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/290317955.md) - [en](https://longbridge.com/en/news/290317955.md) - [zh-HK](https://longbridge.com/zh-HK/news/290317955.md) generator: "portal-rs" --- # EHang Holdings Limited Stock 12‑Month Price Target Cut to $13.15, Implies 87% Upside - According to estimates from 8 analysts, EHang Holdings Limited stock's average price target has fallen from $13.95 to $13.15, with forecasts ranging from $7.99 to $16.9 per share - Based on the Jun. 18 closing price, the updated target implies approximately 87% potential upside - Consensus rating remains at “Buy” across 9 covering analysts, with 7 Buys, 2 Holds and 0 Sells Explore more price target data and ratings for EHang Holdings Limited on the , and track all previous and future analyst recommendations for EHang Holdings Limited in the dedicated News Flow. **Disclaimer** Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice. ### Related Stocks - [EH.US](https://longbridge.com/en/quote/EH.US.md) ## Related News & Research - [EHang partners with CSCEC Sixth Engineering Bureau to develop low-altitude infrastructure in China](https://longbridge.com/en/news/296451021.md) - [EHang Holdings Limited Stock 12‑Month Price Target Cut to $15.63, Implies 79% Upside](https://longbridge.com/en/news/289229053.md) - [Does Interparfums’ (IPAR) Earnings Upgrade Hint At Deeper Strength In Its Profit Model?](https://longbridge.com/en/news/296564505.md) - [CONMED (CNMD) Could Be 8% Overvalued Following Its Recent Rebound](https://longbridge.com/en/news/296318744.md) - [Arcus Biosciences (RCUS) Stock Looks Strong On Returns But Stretched On Sales](https://longbridge.com/en/news/296529363.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**